David Owens brings 30 years of pharmaceutical and biotechnology management and commercialization experience. Mr. Owens was formerly the CBO for Novira Therapeutics, Inc., a privately held antiviral drug discovery company, were he led a syndicated angel investment in 2011 and then a $30MM Series A in 2012. Prior to Novira, Mr. Owens held executive positions as Sr VP at King Pharmaceuticals and VP of Global Marketing & Medical Affairs at Aventis.

Dr. Goforth has over 13 years experience in functional protein design and production. She has published over a dozen scientific papers in the fields of biochemistry and bioengineering. Dr. Goforth has also been principal investigator and co-PI on over $15MM in NIH, DoD, Department of Energy, and Small Business Innovation Research grants. She also serves as an appointed member of the State of Arkansas Science Advisory Committee.

Dr. Gensure is one of the inventors of PTH-CBD and is a board-certified pediatric endocrinologist at the Tufts Medical Center in Boston. Dr. Gensure graduated from Tulane University School of Medicine and completed his residency and fellowship at Massachusetts General Hospital. Dr. Gensure has significant research experience and has published extensively on the physiological roles of PTH.